Immunology and immunomodulation of corneal transplantation

International Reviews of Immunology

Volumn 21, Issue 2-3, 2002, Pages 173-196

  Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cornea; Immune modulation; Immune privilege; Keratoplasty; Rejection

Indexed keywords

ANIMAL; ANTERIOR CHAMBER; COMPLEMENT; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE TOLERANCE; ISOANTIBODIES; LANGERHANS CELLS; MEMBRANE GLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; ANIMALS; COMPLEMENT SYSTEM PROTEINS; FAS LIGAND PROTEIN; HUMANS;

ALLOANTIBODY; COMPLEMENT; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

ALLOTRANSPLANTATION; ANIMAL; ANTERIOR EYE CHAMBER; CORNEA TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LANGERHANS CELL; PHYSIOLOGY; REVIEW; T LYMPHOCYTE;

EID: 0035997395     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180212064     Document Type: Review

References (92)

1. T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection
2. Antigen processing and presentation in transplantation
3. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody
4. Dendritic cells and the control of immunity
5. The role of afferent lymphatics in the rejection of skin homografts
6. Sex chromatin as a biologic cell marker in the study of the fate of corneal transplants
7. An inquiry into the possibility of transplanting the cornea with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure
8. + T cells in allorecognition: Lessons from corneal transplantation
9. Characteristics of rejection of orthotopic corneal allografts in the rat
10. Histopathology of rejected orthotopic corneal grafts in the rat
11. Prolongation of survival of primary renal allografts by feeding of donor spleen cells
12. Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor
13. Function and cell surface phenotype of dendritic cells from rat cornea
14. A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique
15. Topical interleukin-1 receptor antagonist promotes corneal transplant survival
16. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts
17. Corneal graft rejection probably mediated by antibodies
18. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis
19. Balancing the immune system for tolerance: A case for regulatory CD4 cells
20. Corneal allograft rejection
21. Protection of corneal allografts by CTLA4-Ig
22. Prolonged survival of corneal allografts incubated in alloantibody fragments
23. A role for eosinophils in transplant rejection
24. A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation
25. Corneal transplantation in antibody-deficient hosts
26. The role of FasL-induced apoptosis in immune privilege
27. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients
28. Cells mediating allograft rejection
29. Fate of cells in the transplant
30. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival
31. The effect of oral immunization on corneal allograft survival
32. Depletion of donor-derived Langerhans cells promotes corneal allograft survival
33. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody
34. The role of cytotoxic T lymphocytes in corneal allograft rejection
35. Inhibition of corneal allograft reaction by CTLA4-Ig
36. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes
37. Suppressor T cells in mice made unresponsive to skin allografts
38. Circulating cornea-specific antibodies in corneal disease and cornea transplantation
39. Induction of corneal graft rejection by passive cell transfer
40. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10
41. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes
42. Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts
43. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland
44. Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens
45. Contribution of direct and indirect recognition pathways to T cell alloreactivity
46. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
47. Oral immunisation as a strategy for enhancing corneal allograft survival
48. Conditions affecting enhanced corneal allograft survival by oral immunization
49. T cell subsets in the immune rejection of murine heterotopic corneal allografts
50. The influence of donor-recipient sensitization on corneal grafts
51. The expanding universe of T-cell subsets: Th1, Th2 and more
52. Animal models of corneal transplantation
53. Anterior chamber-associated immune deviation
54. The immune privilege of corneal allografts
55. The immunology of corneal transplantation
56. Anterior chamber-associated immune deviation promotes corneal allograft survival
57. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea
58. Antigen presentation by Langerhans cells in vivo: Donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens
59. Composition of cellular infiltrates in rejected human corneal allografts
60. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model
61. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression
62. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response
63. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts
64. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen
65. Ability of intracamerally inoculated B- and T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival
66. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival
67. Clinical and immunological results of corneal allograft rejection
68. Lymphatic drainage from vascularized rabbit cornea
69. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59
70. Orthotopic corneal transplantation in mice - Evidence that the immunogenetic rules of rejection do not apply
71. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts
72. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation
73. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments
74. Heterotopic corneal grafting in mice: A new approach to the study of corneal alloimmunity
75. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
76. Effect of donor epithelium on corneal transplant survival
77. The collaborative corneal transplantation studies
78. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
79. The relative immunogenicity of corneal epithelium, stroma, and endothelium. The role of major histocompatibility complex antigens
80. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate
81. The distribution of HLA antigens on human corneal tissue
82. Penetrating corneal transplantation in the inbred rat: A new model
83. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells
84. The Fas-Fas ligand system and other modulators of apoptosis in the cornea
85. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice
86. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in 'high risk' eyes
87. The critical role of lymph nodes in corneal alloimmunization and graft rejection
88. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants
89. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation
90. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice
91. + regulatory cells
92. Eine erfolgreiche totale keratoplastik